Panacea Index Logo

Command Palette

Search for a command to run...

Online yoga in myeloproliferative neoplasm patients: results of a randomized pilot trial to inform future research.

BMC complementary and alternative medicine
January 1, 1970
Jennifer Huberty et al. (7 authors)
Journal ArticleRandomized Controlled TrialHuman StudyClinical
Study Details

Study Goal

The researchers aimed to explore the limited efficacy of a 12-week online yoga intervention on symptom burden and quality of life in MPN patients and assess the feasibility of remotely collecting inflammatory biomarkers.

Results Summary

The study found small to moderate effects of online yoga on sleep disturbance, pain intensity, anxiety, and depression, with a notable decrease in TNF-α levels. Remote blood collection was deemed feasible, though larger trials are needed to confirm efficacy.

Population

Myeloproliferative neoplasm (MPN) patients

Effective Dosage

60 minutes per week of yoga

Duration

12 weeks

Interactions

None mentioned

Extracted Claims (6)
InterventionDirectionEndpointPopulationDosageImpactClaim #
a 12-week online yoga intervention
decrease
sleep
MPN patients
d = -0.26 to -0.61
demonstrated small effects
#1
a 12-week online yoga intervention
decrease
pain
MPN patients
d = -0.34 to -0.51
demonstrated small effects
#2
a 12-week online yoga intervention
decrease
anxiety
MPN patients
d = -0.27 to -0.37
demonstrated small effects
#3
a 12-week online yoga intervention
decrease
depression
MPN patients
d = -0.53 to -0.78
demonstrated a moderate effect
#4
a 12-week online yoga intervention
decrease
TNF-α
online yoga participants
-1.3 ± 1.5 pg/ml
there was a decrease
#5
online yoga
decrease
TNF-α
online yoga participants
large
the effect size of the intervention on TNF-α was large
#6
Abstract

BACKGROUND: Myeloproliferative neoplasm (MPN) patients suffer from significant symptoms, inflammation and reduced quality of life. Yoga improves these outcomes in other cancers, but this hasn't been demonstrated in MPNs. The purpose of this study was to: (1) explore the limited efficacy (does the program show promise of success) of a 12-week online yoga intervention among MPN patients on symptom burden and quality of life and (2) determine feasibility (practicality: to what extent a measure can be carried out) of remotely collecting inflammatory biomarkers. METHODS: Patients were recruited nationally and randomized to online yoga (60 min/week of yoga) or wait-list control (asked to maintain normal activity). Weekly yoga minutes were collected with Clicky (online web analytics tool) and self-report. Those in online yoga completed a blood draw at baseline and week 12 to assess inflammation (interleukin-6, tumor necrosis factor-alpha [TNF-α]). All participants completed questionnaires assessing depression, anxiety, fatigue, pain, sleep disturbance, sexual function, total symptom burden, global health, and quality of life at baseline, week seven, 12, and 16. Change from baseline at each time point was computed by group and effect sizes were calculated. Pre-post intervention change in inflammation for the yoga group was compared by t-test. RESULTS: Sixty-two MPN patients enrolled and 48 completed the intervention (online yoga = 27; control group = 21). Yoga participation averaged 40.8 min/week via Clicky and 56.1 min/week via self-report. Small/moderate effect sizes were generated from the yoga intervention for sleep disturbance (d = - 0.26 to - 0.61), pain intensity (d = - 0.34 to - 0.51), anxiety (d = - 0.27 to - 0.37), and depression (d = - 0.53 to - 0.78). A total of 92.6 and 70.4% of online yoga participants completed the blood draw at baseline and week 12, respectively, and there was a decrease in TNF-α from baseline to week 12 (- 1.3 ± 1.5 pg/ml). CONCLUSIONS: Online yoga demonstrated small effects on sleep, pain, and anxiety as well as a moderate effect on depression. Remote blood draw procedures are feasible and the effect size of the intervention on TNF-α was large. Future fully powered randomized controlled trials are needed to test for efficacy. TRIAL REGISTRATION: This trial was retrospectively registered with clinicaltrials.gov (ID: NCT03503838 ) on 4/19/2018.

Medical Subject Headings (MeSH)
AdultAgedBiomarkersFeasibility StudiesHumansInflammationMiddle AgedMyeloproliferative DisordersPatient Reported Outcome MeasuresPilot ProjectsQuality of LifeYoga
Study Links
Quality Scores
SafetyNot Assessed
Efficacy65/10
Quality75/10
Citation Metrics
Total Citations54
Citations/Year9.0
Relative Citation Ratio3.35
NIH Percentile87.2%
Research Impact Scores
APT Score0.95
Weight Score1.80
Normalized Score0.61
Related Supplements
Online yoga in myeloproliferative neoplasm patients: results... | Panacea Index